Rosetta Genomics Ltd (NASDAQ:ROSG)

Data as of Sep 19
 -0.20 / -5.24%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Rosetta Genomics Ltd. is seeking to develop and commercialize new diagnostic tests and therapeutics based on a group of genes known as microRNAs. MicroRNAs are naturally expressed, or produced, using instructions encoded in DNA and are believed to play an important role in normal function and in various pathologies. The company's cancer testing services are available through its Philadelphia-based CAP-accredited and CLIA-certified lab. Rosetta Genomics was founded in March 2000 by Bentwich Isaac and is headquartered in Rehovot, Israel.

Contact Information

Rosetta Genomics Ltd.
10 Plaut Street
Rehovot -- 76706
Investor Relations:



Other institutional4.36%
Mutual fund holders0.24%
Individual stakeholders--

Top Executives

Kenneth A. BerlinPresident, CEO & Head-Investor Relations
Ron KalfusChief Financial Officer
Eti MeiriVice President-Research
E. Robert WassmanChief Medical Officer
Dganit BarChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.